Today's Daily Dose brings you news about FDA approval of the first needle-free treatment for severe hypoglycemia; mixed results from Bristol-Myers' CheckMate -227 trial; merger of Gemphire Therapeutics with a privately-held company; and reverse stock split of Pluristem Therapeutics, among others.
from RTT - Biotech https://ift.tt/2JPpfDb
via IFTTT
No comments:
Post a Comment